Camilan Tablets (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
MFDS item code 199603326 · Notified 1996.04.06
This product's status changed to Approval withdrawn on 2024.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This medication is used to treat diseases related to excessive stomach acid, such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson's syndrome during preoperative anesthesia and in treating gastric and duodenal ulcers caused by NSAID use. It improves symptoms of acute exacerbation of acute gastritis and chronic gastritis, as well as bleeding, erosion, redness, and swelling symptoms caused by peptic ulcers or acute gastric mucosal lesions. The liquid form also helps relieve heartburn or regurgitation due to excessive stomach acid. In summary, this medication is used to treat and improve various gastrointestinal mucosal diseases and excessive stomach acid symptoms.
Take 150 mg of ranitidine per dose twice daily, orally in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 150 mg of this medicine per dose twice daily orally, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 300 mg per dose twice daily, in the morning and at bedtime. The dosage is the same for combination therapy to treat ulcers caused by administration of nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. These conditions generally heal within 4 weeks, and conditions caused by administration of nonsteroidal anti-inflammatory drugs generally heal within 8 weeks; however, healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 150 mg of this medicine per dose twice daily, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g daily may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine per dose twice daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug, so readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted appropriately according to age and symptoms.
For patients 12 years of age or older, administer 75 mg of this medicine per dose twice daily by mouth (oral solution only). For patients aged 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This medication should not be used in patients who are allergic to any components of this medication or have had hypersensitivity reactions. It should not be administered to patients with a history of acute porphyria as it may worsen symptoms. This medication contains lactose and should not be administered to patients with lactose intolerance or specific hereditary metabolic disorders. Patients with reduced kidney function should have dosage reduced or dosing intervals increased as this medication may remain in the body longer. Patients with impaired liver function should also be administered with caution, and careful administration is needed for those with a history of drug allergies and elderly patients. Patients taking nonsteroidal anti-inflammatory drugs should pay special attention, and those aged middle-aged or older with a history of gastric ulcers or newly developed dyspeptic symptoms should confirm the presence of malignancies before administration. Patients with gastric and duodenal ulcers infected by Helicobacter pylori should undergo bacterial eradication treatment concurrently. This medication can rarely cause severe allergic reactions or various side effects such as blood abnormalities, liver dysfunction, neurological disorders, and skin rashes, so if any abnormal symptoms occur, administration should be stopped immediately and medical attention should be sought. During treatment, the patient's condition should be carefully monitored and only the minimum effective dosage should be used; if there is no effect, other treatment methods should be considered. Particularly elderly patients, those with chronic lung diseases, diabetic patients, and immunocompromised patients may be at higher risk of developing pneumonia, so caution is advised. If dizziness or drowsiness occurs after taking this medication, driving or operating dangerous machinery should be avoided. This medication may affect the absorption or excretion of other medications, so dosages may need adjustment or discontinuation of concurrent medications must be discussed with healthcare professionals. Women who are pregnant or may become pregnant should use this medication cautiously only when necessary, and nursing women should take it only if necessary as it may be transferred into breast milk. Safety in children has not been sufficiently established, so caution is advised in its use. Elderly patients should adjust the dosage as this medication may remain in the body longer due to reduced kidney function. This medication may lead to false positive reactions in urine protein tests, so care should be taken regarding the test method. In case of overdose, vomiting or gastric lavage may be needed, and in severe cases, hemodialysis may be used to remove the medication. This medication should be stored out of reach of children, and transferring it to another container should be avoided as it may cause quality degradation or accident risk. Long-term use may lead to bacterial overgrowth in the stomach due to reduced gastric acid secretion and may bind to ocular melanin, thus ophthalmologic assessments may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that blocks light, in a dry place without moisture. This way, the effectiveness of the medication can be well maintained and deterioration can be prevented.
White, round, film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.